BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 14, 2008
View Archived Issues
Talecris Opts for $3.1B Merger Instead of IPO
Talecris Biotherapeutics Inc. said it is being acquired by Australian firm CSL Ltd. in a $3.1 billion cash merger that would form one of the largest plasma-derived therapeutics firms worldwide. (BioWorld Today)
Read More
Genentech Rejects Roche Offer, as Biotech's Shares Near $100
Read More
Immune Suppressant Can Stimulate Immune System
Read More
Anthera Raises $19M to Boost Work in Anti-inflammatories
Read More
Clinic Roundup
Read More
Other News To Note
Read More
Earnings Roundup
Read More